InvestorsHub Logo
Followers 16
Posts 1062
Boards Moderated 0
Alias Born 09/01/2019

Re: Money $hot post# 14961

Monday, 09/06/2021 4:37:52 PM

Monday, September 06, 2021 4:37:52 PM

Post# of 16698
Beyond all that, a Clinical trial should have a 'peer reviewed' publication of results.
Shareholders paid for it.
Just like the Dr Yost research being used now by BLO and what he took to Bellus.
Dr Williams was Well Paid for his Drug research when BTH re-merged with NASH and an evaluation including a final 'paper' is owed. If he will not/does not give some peer reviewed report, the new CSO and teams should, IMO.

The CT had this BS...
"Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: Undecided"

We can 'HOPE' there is IPF/CC data for Ifenprodil that is confirmed by data from the COVID CT. Combined there may be 'significant' results.?.
Enough to sell? Partner? Pump?

Tumors/Cancer/PF/ARDS.?.
...GLTA...